Heyam Saad Ali*
Professor, University of Khartoum, Sudan
*Corresponding Author: Heyam Saad Ali, Professor, University of Khartoum, Sudan.
Received: December 04, 2019; Published: December 06, 2019
Traditional chemotherapy is not recommended in the clinical settings due the severe complications patients excercising during use. Some of these complications include: severe systemic problems, [MDR] and toxicity. The reasons of such off-targeted side effects are due to the poor specificity and selectivity of drug deliver systems to target the biological molecule in the site of cancerous tissue. Therefore, advancement in the targeted delivery systems using nanotechnology techniques and nanocarriers are the area of interest and attention of many researchers, scientists and academians.
Currently, significant developments, approaches and strategies are utilized to target the cancerous tissue. From these strategies of targeting the drug delivery is using nanocarriers such as liposomes, polymer nanoparticles, dandrimers etc. In addition to strengthen the conjugation to the selected extracellular and intracellular biological molecules such as receptors, carbohydrate determinant antigen, antibodie etc.
Citation: Heyam Saad Ali. "Targeted Liposomes and Theranostic Applications in Cancer Treatment".Acta Scientific Pharmaceutical Sciences 4.1 (2020): 15.
Copyright: © 2020 Heyam Saad Ali. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.